Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion description "[In the current study, we examined a panel of serially passaged glioblastoma xenografts, in the context of an intracranial tumor therapy response model, to identify associations between glioblastoma molecular characteristics and tumor sensitivity to the epidermal growth factor receptor (EGFR) kinase inhibitor erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion evidence source_evidence_literature NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion SIO_000772 17363510 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion wasDerivedFrom befree-2016 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion wasGeneratedBy ECO_0000203 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- befree-2016 importedOn "2016-02-19" NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.